LIPG

lipase G, endothelial type, the group of Lipases

Basic information

Region (hg38): 18:49560699-49599185

Links

ENSG00000101670NCBI:9388OMIM:603684HGNC:6623Uniprot:Q9Y5X9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LIPG gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LIPG gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
32
clinvar
3
clinvar
36
missense
51
clinvar
5
clinvar
8
clinvar
64
nonsense
0
start loss
0
frameshift
2
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
3
clinvar
3
splice region
1
4
1
6
non coding
1
clinvar
6
clinvar
5
clinvar
12
Total 0 0 58 43 16

Variants in LIPG

This is a list of pathogenic ClinVar variants found in the LIPG region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-49562308-G-T LIPG-related disorder Likely benign (Aug 29, 2019)3052719
18-49562320-C-A Benign (Jan 31, 2024)1635172
18-49562344-C-T Likely benign (Aug 19, 2023)2722876
18-49562371-C-T Benign (Jan 31, 2024)1592089
18-49562377-A-C Likely benign (Oct 17, 2021)1594800
18-49562378-C-T not specified Uncertain significance (Dec 13, 2022)2334603
18-49562384-G-A Benign (Jan 31, 2024)1169605
18-49562419-G-A Likely benign (Oct 14, 2022)1910664
18-49565330-A-C Uncertain significance (Oct 04, 2023)2765391
18-49565334-A-C Benign (Dec 26, 2023)1535219
18-49565335-A-C not specified Uncertain significance (Nov 29, 2023)3119068
18-49565352-G-A Uncertain significance (Apr 28, 2021)1391514
18-49565379-C-T Uncertain significance (May 09, 2023)1490993
18-49565400-C-G Uncertain significance (Jun 27, 2022)1936533
18-49565423-C-T Likely benign (Oct 28, 2023)2891737
18-49565437-C-T Benign (Nov 15, 2023)1607238
18-49565448-T-C Uncertain significance (Mar 02, 2023)2891476
18-49565490-G-A Uncertain significance (Nov 23, 2022)2821724
18-49565506-C-T Likely benign (Nov 28, 2023)2983706
18-49567426-C-G Benign (Jan 24, 2024)1603010
18-49567444-G-T Uncertain significance (May 18, 2022)1942660
18-49567447-C-T Likely benign (Oct 20, 2023)2861796
18-49567453-C-T Likely benign (Oct 18, 2023)2989731
18-49567478-G-A Uncertain significance (May 25, 2022)1944287
18-49567490-C-T not specified Uncertain significance (Apr 27, 2023)2541480

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LIPGprotein_codingprotein_codingENST00000261292 1032204
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.02e-100.2951256730751257480.000298
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8572572990.8600.00001903319
Missense in Polyphen103130.550.788951471
Synonymous-1.201341171.140.00000808945
Loss of Function0.9071822.70.7940.00000116267

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002060.000206
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.002080.00208
European (Non-Finnish)0.0001320.000114
Middle Eastern0.0001630.000163
South Asian0.0002290.000229
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has phospholipase and triglyceride lipase activities. Hydrolyzes high density lipoproteins (HDL) more efficiently than other lipoproteins. Binds heparin.;
Pathway
Glycerolipid metabolism - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);HDL remodeling;Transport of small molecules;Glycerophospholipid metabolism;triacylglycerol degradation;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein remodeling (Consensus)

Recessive Scores

pRec
0.336

Intolerance Scores

loftool
0.249
rvis_EVS
0.49
rvis_percentile_EVS
79.46

Haploinsufficiency Scores

pHI
0.180
hipred
Y
hipred_score
0.615
ghis
0.435

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.766

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lipg
Phenotype
homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Gene ontology

Biological process
lipid metabolic process;response to nutrient;cell population proliferation;phospholipid catabolic process;positive regulation of high-density lipoprotein particle clearance;positive regulation of cholesterol transport;high-density lipoprotein particle remodeling;cholesterol homeostasis;reverse cholesterol transport;regulation of lipoprotein metabolic process;phospholipid homeostasis
Cellular component
extracellular region;extracellular space;early endosome;Golgi apparatus;cell surface
Molecular function
lipoprotein lipase activity;phospholipase activity;heparin binding;phospholipase A1 activity